|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5377 | (2013.01) |
| C07D 487/04 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/122 | (2013.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61K 31/235 | (2013.01) | ||
| A61K 31/42 | (2013.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/4706 | (2013.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/593 | (2013.01) | ||
| A61K 31/7135 | (2013.01) | ||
| A61K 31/728 | (2013.01) | ||
| C07D 487/04 | (2013.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3490565 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17835338.9 |
| Date of filing the European patent application | 2017-07-28 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/044369 |
| Date | 2017-07-28 |
| (87) | Number | WO 2018/022992 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201662368848 P | 2016-07-29 | US | |
| 201662426087 P | 2016-11-23 | US |
| (72) |
BECK, Hilary, Plake , US
BIANNIC, Berenger , US
BUI, Minna Hue, Thanh , US
HU, Dennis, X. , US
KETCHAM, John, Michael , US
POWERS, Jay, Patrick , US
REILLY, Maureen, Kay , US
ROBLES-RESENDIZ, Omar , US
SHUNATONA, Hunter, Paul , US
WALKER, James, Ross , US
WUSTROW, David, Juergen , US
YOUNAI, Ashkaan , US
ZIBINSKY, Mikhail , US
JACKSON, Jeffrey James , US
|
| (73) |
RAPT Therapeutics, Inc. ,
561 Eccles Avenue, South San Francisco, CA 94080,
US
|
| (54) | AZETIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF |
| AZETIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF |